Table of Content

1 Study Coverage
1.1 Human Gene Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Human Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Non-viral Vectors
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Human Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 DMD (Duchenne Muscular Dystrophy)
1.3.5 Hepatological Diseases
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Gene Therapy Sales Estimates and Forecasts 2018-2029
2.2 Global Human Gene Therapy Revenue by Region
2.2.1 Global Human Gene Therapy Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Gene Therapy Revenue by Region (2018-2024)
2.2.3 Global Human Gene Therapy Revenue by Region (2024-2029)
2.2.4 Global Human Gene Therapy Revenue Market Share by Region (2018-2029)
2.3 Global Human Gene Therapy Sales Estimates and Forecasts 2018-2029
2.4 Global Human Gene Therapy Sales by Region
2.4.1 Global Human Gene Therapy Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Gene Therapy Sales by Region (2018-2024)
2.4.3 Global Human Gene Therapy Sales by Region (2024-2029)
2.4.4 Global Human Gene Therapy Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Gene Therapy Sales by Manufacturers
3.1.1 Global Human Gene Therapy Sales by Manufacturers (2018-2024)
3.1.2 Global Human Gene Therapy Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Gene Therapy in 2022
3.2 Global Human Gene Therapy Revenue by Manufacturers
3.2.1 Global Human Gene Therapy Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Gene Therapy Revenue in 2022
3.3 Global Key Players of Human Gene Therapy, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Gene Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Gene Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Gene Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Human Gene Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Gene Therapy Sales by Type
4.1.1 Global Human Gene Therapy Historical Sales by Type (2018-2024)
4.1.2 Global Human Gene Therapy Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Gene Therapy Sales Market Share by Type (2018-2029)
4.2 Global Human Gene Therapy Revenue by Type
4.2.1 Global Human Gene Therapy Historical Revenue by Type (2018-2024)
4.2.2 Global Human Gene Therapy Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Gene Therapy Revenue Market Share by Type (2018-2029)
4.3 Global Human Gene Therapy Price by Type
4.3.1 Global Human Gene Therapy Price by Type (2018-2024)
4.3.2 Global Human Gene Therapy Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Gene Therapy Sales by Application
5.1.1 Global Human Gene Therapy Historical Sales by Application (2018-2024)
5.1.2 Global Human Gene Therapy Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Gene Therapy Sales Market Share by Application (2018-2029)
5.2 Global Human Gene Therapy Revenue by Application
5.2.1 Global Human Gene Therapy Historical Revenue by Application (2018-2024)
5.2.2 Global Human Gene Therapy Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Gene Therapy Revenue Market Share by Application (2018-2029)
5.3 Global Human Gene Therapy Price by Application
5.3.1 Global Human Gene Therapy Price by Application (2018-2024)
5.3.2 Global Human Gene Therapy Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Gene Therapy Market Size by Type
6.1.1 US & Canada Human Gene Therapy Sales by Type (2018-2029)
6.1.2 US & Canada Human Gene Therapy Revenue by Type (2018-2029)
6.2 US & Canada Human Gene Therapy Market Size by Application
6.2.1 US & Canada Human Gene Therapy Sales by Application (2018-2029)
6.2.2 US & Canada Human Gene Therapy Revenue by Application (2018-2029)
6.3 US & Canada Human Gene Therapy Market Size by Country
6.3.1 US & Canada Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Gene Therapy Sales by Country (2018-2029)
6.3.3 US & Canada Human Gene Therapy Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Gene Therapy Market Size by Type
7.1.1 Europe Human Gene Therapy Sales by Type (2018-2029)
7.1.2 Europe Human Gene Therapy Revenue by Type (2018-2029)
7.2 Europe Human Gene Therapy Market Size by Application
7.2.1 Europe Human Gene Therapy Sales by Application (2018-2029)
7.2.2 Europe Human Gene Therapy Revenue by Application (2018-2029)
7.3 Europe Human Gene Therapy Market Size by Country
7.3.1 Europe Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Gene Therapy Sales by Country (2018-2029)
7.3.3 Europe Human Gene Therapy Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Gene Therapy Market Size
8.1.1 China Human Gene Therapy Sales (2018-2029)
8.1.2 China Human Gene Therapy Revenue (2018-2029)
8.2 China Human Gene Therapy Market Size by Application
8.2.1 China Human Gene Therapy Sales by Application (2018-2029)
8.2.2 China Human Gene Therapy Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Gene Therapy Market Size by Type
9.1.1 Asia Human Gene Therapy Sales by Type (2018-2029)
9.1.2 Asia Human Gene Therapy Revenue by Type (2018-2029)
9.2 Asia Human Gene Therapy Market Size by Application
9.2.1 Asia Human Gene Therapy Sales by Application (2018-2029)
9.2.2 Asia Human Gene Therapy Revenue by Application (2018-2029)
9.3 Asia Human Gene Therapy Sales by Region
9.3.1 Asia Human Gene Therapy Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Gene Therapy Revenue by Region (2018-2029)
9.3.3 Asia Human Gene Therapy Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Gene Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Gene Therapy Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Gene Therapy Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Gene Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Gene Therapy Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Gene Therapy Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Gene Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Gene Therapy Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Gene Therapy Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Overview
11.1.3 Biogen Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Biogen Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biogen Recent Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Information
11.2.2 Sarepta Therapeutics Overview
11.2.3 Sarepta Therapeutics Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sarepta Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sarepta Therapeutics Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Overview
11.3.3 Gilead Sciences Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Gilead Sciences Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gilead Sciences Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Amgen Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Orchard Therapeutics
11.6.1 Orchard Therapeutics Company Information
11.6.2 Orchard Therapeutics Overview
11.6.3 Orchard Therapeutics Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Orchard Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Orchard Therapeutics Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Overview
11.7.3 Spark Therapeutics Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Spark Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Spark Therapeutics Recent Developments
11.8 Agc Biologics
11.8.1 Agc Biologics Company Information
11.8.2 Agc Biologics Overview
11.8.3 Agc Biologics Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Agc Biologics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Agc Biologics Recent Developments
11.9 Anges
11.9.1 Anges Company Information
11.9.2 Anges Overview
11.9.3 Anges Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Anges Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Anges Recent Developments
11.10 Bluebird Bio
11.10.1 Bluebird Bio Company Information
11.10.2 Bluebird Bio Overview
11.10.3 Bluebird Bio Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Bluebird Bio Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bluebird Bio Recent Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Overview
11.11.3 Jazz Pharmaceuticals Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Jazz Pharmaceuticals Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jazz Pharmaceuticals Recent Developments
11.12 Dynavax Technologies
11.12.1 Dynavax Technologies Company Information
11.12.2 Dynavax Technologies Overview
11.12.3 Dynavax Technologies Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Dynavax Technologies Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dynavax Technologies Recent Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Overview
11.13.3 Human Stem Cells Institute Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Human Stem Cells Institute Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Human Stem Cells Institute Recent Developments
11.14 Sibiono Genetech
11.14.1 Sibiono Genetech Company Information
11.14.2 Sibiono Genetech Overview
11.14.3 Sibiono Genetech Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Sibiono Genetech Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sibiono Genetech Recent Developments
11.15 Shanghai Sunway Biotech
11.15.1 Shanghai Sunway Biotech Company Information
11.15.2 Shanghai Sunway Biotech Overview
11.15.3 Shanghai Sunway Biotech Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Shanghai Sunway Biotech Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shanghai Sunway Biotech Recent Developments
11.16 Uniqure N.V.
11.16.1 Uniqure N.V. Company Information
11.16.2 Uniqure N.V. Overview
11.16.3 Uniqure N.V. Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Uniqure N.V. Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Uniqure N.V. Recent Developments
11.17 Gensight Biologics S.A.
11.17.1 Gensight Biologics S.A. Company Information
11.17.2 Gensight Biologics S.A. Overview
11.17.3 Gensight Biologics S.A. Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Gensight Biologics S.A. Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Gensight Biologics S.A. Recent Developments
11.18 Celgene Corporation
11.18.1 Celgene Corporation Company Information
11.18.2 Celgene Corporation Overview
11.18.3 Celgene Corporation Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Celgene Corporation Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Celgene Corporation Recent Developments
11.19 Cellectis
11.19.1 Cellectis Company Information
11.19.2 Cellectis Overview
11.19.3 Cellectis Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Cellectis Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Cellectis Recent Developments
11.20 Sangamo Therapeutics
11.20.1 Sangamo Therapeutics Company Information
11.20.2 Sangamo Therapeutics Overview
11.20.3 Sangamo Therapeutics Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Sangamo Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Sangamo Therapeutics Recent Developments
11.21 Mustang Bio
11.21.1 Mustang Bio Company Information
11.21.2 Mustang Bio Overview
11.21.3 Mustang Bio Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Mustang Bio Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Mustang Bio Recent Developments
11.22 AGTC
11.22.1 AGTC Company Information
11.22.2 AGTC Overview
11.22.3 AGTC Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 AGTC Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 AGTC Recent Developments
11.23 Poseida Therapeutics
11.23.1 Poseida Therapeutics Company Information
11.23.2 Poseida Therapeutics Overview
11.23.3 Poseida Therapeutics Human Gene Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 Poseida Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Poseida Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Gene Therapy Industry Chain Analysis
12.2 Human Gene Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Gene Therapy Production Mode & Process
12.4 Human Gene Therapy Sales and Marketing
12.4.1 Human Gene Therapy Sales Channels
12.4.2 Human Gene Therapy Distributors
12.5 Human Gene Therapy Customers
13 Market Dynamics
13.1 Human Gene Therapy Industry Trends
13.2 Human Gene Therapy Market Drivers
13.3 Human Gene Therapy Market Challenges
13.4 Human Gene Therapy Market Restraints
14 Key Findings in The Global Human Gene Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Non-viral Vectors
Table 3. Major Manufacturers of Viral Vectors
Table 4. Global Human Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Human Gene Therapy Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Human Gene Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Human Gene Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Human Gene Therapy Revenue Market Share by Region (2018-2024)
Table 9. Global Human Gene Therapy Revenue Market Share by Region (2024-2029)
Table 10. Global Human Gene Therapy Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Human Gene Therapy Sales by Region (2018-2024) & (K Units)
Table 12. Global Human Gene Therapy Sales by Region (2024-2029) & (K Units)
Table 13. Global Human Gene Therapy Sales Market Share by Region (2018-2024)
Table 14. Global Human Gene Therapy Sales Market Share by Region (2024-2029)
Table 15. Global Human Gene Therapy Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Human Gene Therapy Sales Share by Manufacturers (2018-2024)
Table 17. Global Human Gene Therapy Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Human Gene Therapy Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Human Gene Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Human Gene Therapy Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Human Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2022)
Table 23. Global Key Manufacturers of Human Gene Therapy, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Human Gene Therapy, Product Offered and Application
Table 25. Global Key Manufacturers of Human Gene Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 28. Global Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 29. Global Human Gene Therapy Sales Share by Type (2018-2024)
Table 30. Global Human Gene Therapy Sales Share by Type (2024-2029)
Table 31. Global Human Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Human Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Human Gene Therapy Revenue Share by Type (2018-2024)
Table 34. Global Human Gene Therapy Revenue Share by Type (2024-2029)
Table 35. Human Gene Therapy Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Human Gene Therapy Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 38. Global Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 39. Global Human Gene Therapy Sales Share by Application (2018-2024)
Table 40. Global Human Gene Therapy Sales Share by Application (2024-2029)
Table 41. Global Human Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Human Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Human Gene Therapy Revenue Share by Application (2018-2024)
Table 44. Global Human Gene Therapy Revenue Share by Application (2024-2029)
Table 45. Human Gene Therapy Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Human Gene Therapy Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Human Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Human Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Human Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Human Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Human Gene Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 60. Europe Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 61. Europe Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 62. Europe Human Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Human Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 65. Europe Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 66. Europe Human Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Human Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Human Gene Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 72. Europe Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 73. China Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 74. China Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 75. China Human Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Human Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 78. China Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 79. China Human Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Human Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 82. Asia Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 83. Asia Human Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Human Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 86. Asia Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 87. Asia Human Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Human Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Human Gene Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Human Gene Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Human Gene Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Human Gene Therapy Sales by Region (2018-2024) & (K Units)
Table 93. Asia Human Gene Therapy Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Human Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Human Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Human Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Human Gene Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 107. Biogen Company Information
Table 108. Biogen Description and Major Businesses
Table 109. Biogen Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Biogen Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Biogen Recent Developments
Table 112. Sarepta Therapeutics Company Information
Table 113. Sarepta Therapeutics Description and Major Businesses
Table 114. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sarepta Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sarepta Therapeutics Recent Developments
Table 117. Gilead Sciences Company Information
Table 118. Gilead Sciences Description and Major Businesses
Table 119. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Gilead Sciences Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Gilead Sciences Recent Developments
Table 122. Amgen Company Information
Table 123. Amgen Description and Major Businesses
Table 124. Amgen Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Amgen Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Amgen Recent Developments
Table 127. Novartis Company Information
Table 128. Novartis Description and Major Businesses
Table 129. Novartis Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Novartis Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novartis Recent Developments
Table 132. Orchard Therapeutics Company Information
Table 133. Orchard Therapeutics Description and Major Businesses
Table 134. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Orchard Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Orchard Therapeutics Recent Developments
Table 137. Spark Therapeutics Company Information
Table 138. Spark Therapeutics Description and Major Businesses
Table 139. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Spark Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Spark Therapeutics Recent Developments
Table 142. Agc Biologics Company Information
Table 143. Agc Biologics Description and Major Businesses
Table 144. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Agc Biologics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Agc Biologics Recent Developments
Table 147. Anges Company Information
Table 148. Anges Description and Major Businesses
Table 149. Anges Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Anges Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Anges Recent Developments
Table 152. Bluebird Bio Company Information
Table 153. Bluebird Bio Description and Major Businesses
Table 154. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Bluebird Bio Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Bluebird Bio Recent Developments
Table 157. Jazz Pharmaceuticals Company Information
Table 158. Jazz Pharmaceuticals Description and Major Businesses
Table 159. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Jazz Pharmaceuticals Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Jazz Pharmaceuticals Recent Developments
Table 162. Dynavax Technologies Company Information
Table 163. Dynavax Technologies Description and Major Businesses
Table 164. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Dynavax Technologies Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Dynavax Technologies Recent Developments
Table 167. Human Stem Cells Institute Company Information
Table 168. Human Stem Cells Institute Description and Major Businesses
Table 169. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Human Stem Cells Institute Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Human Stem Cells Institute Recent Developments
Table 172. Sibiono Genetech Company Information
Table 173. Sibiono Genetech Description and Major Businesses
Table 174. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Sibiono Genetech Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Sibiono Genetech Recent Developments
Table 177. Shanghai Sunway Biotech Company Information
Table 178. Shanghai Sunway Biotech Description and Major Businesses
Table 179. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shanghai Sunway Biotech Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Shanghai Sunway Biotech Recent Developments
Table 182. Uniqure N.V. Company Information
Table 183. Uniqure N.V. Description and Major Businesses
Table 184. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Uniqure N.V. Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Uniqure N.V. Recent Developments
Table 187. Gensight Biologics S.A. Company Information
Table 188. Gensight Biologics S.A. Description and Major Businesses
Table 189. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Gensight Biologics S.A. Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Gensight Biologics S.A. Recent Developments
Table 192. Celgene Corporation Company Information
Table 193. Celgene Corporation Description and Major Businesses
Table 194. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Celgene Corporation Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Celgene Corporation Recent Developments
Table 197. Cellectis Company Information
Table 198. Cellectis Description and Major Businesses
Table 199. Cellectis Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. Cellectis Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Cellectis Recent Developments
Table 202. Sangamo Therapeutics Company Information
Table 203. Sangamo Therapeutics Description and Major Businesses
Table 204. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 205. Sangamo Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Sangamo Therapeutics Recent Developments
Table 207. Mustang Bio Company Information
Table 208. Mustang Bio Description and Major Businesses
Table 209. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 210. Mustang Bio Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Mustang Bio Recent Developments
Table 212. AGTC Company Information
Table 213. AGTC Description and Major Businesses
Table 214. AGTC Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 215. AGTC Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. AGTC Recent Developments
Table 217. Poseida Therapeutics Company Information
Table 218. Poseida Therapeutics Description and Major Businesses
Table 219. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 220. Poseida Therapeutics Human Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 221. Poseida Therapeutics Recent Developments
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Human Gene Therapy Distributors List
Table 225. Human Gene Therapy Customers List
Table 226. Human Gene Therapy Market Trends
Table 227. Human Gene Therapy Market Drivers
Table 228. Human Gene Therapy Market Challenges
Table 229. Human Gene Therapy Market Restraints
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Gene Therapy Product Picture
Figure 2. Global Human Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Gene Therapy Market Share by Type in 2022 & 2029
Figure 4. Non-viral Vectors Product Picture
Figure 5. Viral Vectors Product Picture
Figure 6. Global Human Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Human Gene Therapy Market Share by Application in 2022 & 2029
Figure 8. Neurological Diseases
Figure 9. Cancer
Figure 10. DMD (Duchenne Muscular Dystrophy)
Figure 11. Hepatological Diseases
Figure 12. Others
Figure 13. Human Gene Therapy Report Years Considered
Figure 14. Global Human Gene Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Gene Therapy Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Gene Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Gene Therapy Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Gene Therapy Sales 2018-2029 ((K Units)
Figure 19. Global Human Gene Therapy Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Gene Therapy Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Gene Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Gene Therapy Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Gene Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Gene Therapy Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Gene Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Gene Therapy Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Gene Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Gene Therapy Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Gene Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Gene Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Gene Therapy in the World: Market Share by Human Gene Therapy Revenue in 2022
Figure 32. Global Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Gene Therapy Sales Market Share by Type (2018-2029)
Figure 34. Global Human Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Gene Therapy Sales Market Share by Application (2018-2029)
Figure 36. Global Human Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Gene Therapy Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Gene Therapy Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Gene Therapy Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Gene Therapy Sales Share by Country (2018-2029)
Figure 43. U.S. Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Gene Therapy Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Gene Therapy Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Gene Therapy Revenue Share by Country (2018-2029)
Figure 50. Europe Human Gene Therapy Sales Share by Country (2018-2029)
Figure 51. Germany Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Gene Therapy Sales Market Share by Type (2018-2029)
Figure 57. China Human Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 58. China Human Gene Therapy Sales Market Share by Application (2018-2029)
Figure 59. China Human Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Gene Therapy Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Gene Therapy Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Gene Therapy Revenue Share by Region (2018-2029)
Figure 65. Asia Human Gene Therapy Sales Share by Region (2018-2029)
Figure 66. Japan Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Gene Therapy Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Gene Therapy Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Gene Therapy Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Gene Therapy Sales Share by Country (2018-2029)
Figure 77. Brazil Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 82. Human Gene Therapy Value Chain
Figure 83. Human Gene Therapy Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed